These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9495688)

  • 1. On Miettinen's multivariate confounder score.
    Strauss D
    J Clin Epidemiol; 1998 Mar; 51(3):233-6. PubMed ID: 9495688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some insights into Miettinen's multivariate confounder score approach to case-control study analysis.
    Pike MC; Anderson J; Day N
    Epidemiol Community Health; 1979 Mar; 33(1):104-6. PubMed ID: 467396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using generalized additive models to reduce residual confounding.
    Benedetti A; Abrahamowicz M
    Stat Med; 2004 Dec; 23(24):3781-801. PubMed ID: 15580601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weaknesses of goodness-of-fit tests for evaluating propensity score models: the case of the omitted confounder.
    Weitzen S; Lapane KL; Toledano AY; Hume AL; Mor V
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):227-38. PubMed ID: 15386700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of confounder in epidemiologic data contaminated by measurement error in covariates.
    Lee PH; Burstyn I
    BMC Med Res Methodol; 2016 May; 16():54. PubMed ID: 27193095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders.
    Cepeda MS; Boston R; Farrar JT; Strom BL
    Am J Epidemiol; 2003 Aug; 158(3):280-7. PubMed ID: 12882951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditions for confounding of interactions.
    Liu A; Abrahamowicz M; Siemiatycki J
    Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):287-96. PubMed ID: 26676843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods to assess intended effects of drug treatment in observational studies are reviewed.
    Klungel OH; Martens EP; Psaty BM; Grobbee DE; Sullivan SD; Stricker BH; Leufkens HG; de Boer A
    J Clin Epidemiol; 2004 Dec; 57(12):1223-31. PubMed ID: 15617947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regularized Regression Versus the High-Dimensional Propensity Score for Confounding Adjustment in Secondary Database Analyses.
    Franklin JM; Eddings W; Glynn RJ; Schneeweiss S
    Am J Epidemiol; 2015 Oct; 182(7):651-9. PubMed ID: 26233956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of tube feeding in the mortality of profoundly disabled people with severe mental retardation.
    Kastner T; Criscione T; Walsh K
    Arch Pediatr Adolesc Med; 1994 May; 148(5):537-8. PubMed ID: 8180651
    [No Abstract]   [Full Text] [Related]  

  • 11. A suggestion for improving intelligibility in multivariate confounder adjustment using alcohol intake and birth weight as an example. A 'confounder score' approach in analyzing continuous data.
    Olsen J; Olsen SF
    Scand J Soc Med; 1991 Dec; 19(4):235-41. PubMed ID: 1775958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Number of Events per Confounder for Valid Estimation of Risk Difference Using Modified Least-Squares Regression.
    Hagiwara Y; Fukuda M; Matsuyama Y
    Am J Epidemiol; 2018 Nov; 187(11):2481-2490. PubMed ID: 30060121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubefeeding and mortality in children with severe disabilities and mental retardation.
    Strauss D; Kastner T; Ashwal S; White J
    Pediatrics; 1997 Mar; 99(3):358-62. PubMed ID: 9041288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable Selection for Confounding Adjustment in High-dimensional Covariate Spaces When Analyzing Healthcare Databases.
    Schneeweiss S; Eddings W; Glynn RJ; Patorno E; Rassen J; Franklin JM
    Epidemiology; 2017 Mar; 28(2):237-248. PubMed ID: 27779497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Confounding and interaction in multiple regression].
    Ravani P; Malberti F
    G Ital Nefrol; 2007; 24(1):60-5. PubMed ID: 17342695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A heuristic approach to the formulas for population attributable fraction.
    Hanley JA
    J Epidemiol Community Health; 2001 Jul; 55(7):508-14. PubMed ID: 11413183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The concept of residual confounding in regression models and some applications.
    Becher H
    Stat Med; 1992 Sep; 11(13):1747-58. PubMed ID: 1485057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the impact of confounding (measured and unmeasured) in a case-control study to examine the increased risk of pandemic A/H1N1 associated with receipt of the 2008-9 seasonal influenza vaccine.
    Rosella LC; Groenwold RH; Crowcroft NS
    Vaccine; 2011 Nov; 29(49):9194-200. PubMed ID: 22001885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bias Formulas for Estimating Direct and Indirect Effects When Unmeasured Confounding Is Present.
    le Cessie S
    Epidemiology; 2016 Jan; 27(1):125-32. PubMed ID: 26426943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bias formulas for external adjustment and sensitivity analysis of unmeasured confounders.
    Arah OA; Chiba Y; Greenland S
    Ann Epidemiol; 2008 Aug; 18(8):637-46. PubMed ID: 18652982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.